Medscore Expands Global Reach, Bringing Hope to Filipino Cancer Patients with technology. [Manila, Philippines] – [November 25, 2024] – MedScore, a leading Tech provider of patient access solutions, launched innovative cancer patient access programs offered by global pharmaceutical company.   The program leverages MedScore's innovative affordability scoring solutions (means testing) with geo-location intelligence and banking-level underwriting to digitally assess patients across emerging markets, ensuring they receive the critical treatment they need. ​ MedScore empowers pharmaceutical companies to effectively reach their underserved patients in Vietnam and the Philippines. By utilizing AI-powered scoring technology, MedScore can efficiently evaluate thousands of patients, streamlining the process and granting them access to breakthrough immunology treatment. ​ “Our mission is to bridge the gap between patients in need and life-saving medications,” said Olivia, CEO of MedScore. “With traditional low-digital methods often proving cumbersome and time-consuming, our technology offers a faster, more scalable solution specifically designed for the unique challenges of emerging markets.” MedScore's comprehensive solution offers several key benefits: Enhanced Efficiency : AI-powered assessments streamline the patient evaluation process, enabling pharmaceutical companies to reach a wider pool of qualified patients. Improved Accuracy : Geo-location intelligence and banking-level underwriting ensure accurate patient selection for access programs. Scalability : MedScore's technology can be seamlessly deployed across multiple countries and regions, maximizing program reach. Faster Access to Treatment : By expediting the patient evaluation process, MedScore helps ensure patients receive timely access to critical treatment.

[Singapore] - [November, 2024] – Medscore, a pioneering healthcare technology company, is scheduled to intergrate its innovative means testing software with Singpass, Singapore’s national digital identity platform. ​ This integration empowers healthcare providers to instantly verify patient identity and conduct means testing, streamlining the process of accessing critical medications for underserved patients with cancer and rare diseases. Medscore’s mission is to accelerate drug access for patients in emerging markets by simplifying the complex process of means testing. By leveraging advanced technology and deep healthcare expertise, Medscore empowers healthcare providers to quickly assess patient eligibility for financial assistance programs, ensuring that life-saving medications reach those who need them most. Key Benefits of the Singpass Integration: * Instant Patient Verification:  Real-time verification of patient identity, eliminating manual paperwork and reducing administrative burdens. * Streamlined Means Testing:  Automated assessment of patient financial eligibility, accelerating the approval process. * Enhanced Patient Experience:  A seamless and efficient experience for patients seeking access to vital medications. “We are thrilled to integrate with Singpass, a Singapore GovTech digital identity platform. This developement marks a significant step forward in our mission to improve patient access to life-saving medications,” said Olivia Nguyen, Group CEO at Medscore. “By leveraging technology and simplifying the process, we can empower healthcare providers to focus on delivering quality care and ultimately save lives.” About Medscore Medscore is a healthcare technology company dedicated to improving patient access to essential medications in emerging markets. Our innovative means testing software empowers healthcare providers to efficiently assess patient eligibility for financial assistance programs, ensuring that life-saving treatments reach those who need them most. With a focus on technology, healthcare expertise, and local market knowledge, Medscore is driving positive change in the global healthcare landscape. Media Contact: Med.holdings Communications apac@medscore.io

[Singapore] – [August 1st, 2023] – Medscore , a pioneering healthcare technology company, is committed to transforming the landscape of cancer care in emerging markets. By leveraging advanced means testing software, Medscore empowers patients with cancer and rare diseases to access critical, life-saving treatments that were once out of reach due to affordability challenges ​ The Critical Role of Means Testing to revolutionize access to break-through treatment in emerging markets Means testing is a crucial process that assesses a patient's financial eligibility for subsidized or free medication. In emerging markets, where universal healthcare coverage are limited and patient out-of-pocket expense is high (more than 50%), means testing ensures that essential treatments reach those who need them most. However, traditional methods of means testing can be time-consuming, bureaucratic, and often result in delays or denials of treatment. Medscore’s Innovative Solution Medscore addresses these challenges by providing a cutting-edge software-as-a-service (SaaS) solution that streamlines the means testing process. Our platform leverages advanced algorithms and data analytics to quickly and accurately determine a patient's eligibility for subsidized or free medication. This significantly reduces (10x compared to industry standard) the time it takes for patients to access life-saving treatments, improving their chances of survival and quality of life.  Currently, all means testing process is 100% digital and the fastest rate ever recorded is instant thanks to technology integration and partnership ecosystem enablers such as government tech.. Key Benefits of Medscore: * Accelerated Patient Access : Streamlined means testing leads to faster treatment initiation. * Data-Driven Decision Making:  Real-time analytics empower healthcare providers to make informed decisions. * Localization at scale:  Tech-driven platform which enables any local patient access program regionally, be it language or local nuances in income structure.  About Medscore Medscore is a team of healthcare experts and insurtech technologists dedicated to improving patient outcomes in emerging markets. Our mission is to make life-saving treatments accessible to all, regardless of their financial circumstances. By leveraging technology and local expertise, Medscore is revolutionizing the way healthcare is delivered in these regions.  Media Contact: Med.holdings Communications apac@medscore.io

​ [Hanoi, Vietnam] – [December 28, 2023] – MedScore, a leading software provider of patient access solutions, today received approval from the Vietnam Ministry of Health for its innovative cancer patient access programs offered by global pharmaceutical company.   The program leverages MedScore's innovative scoring solution (Means Testing) with geo-location intelligence and banking-level underwriting to digitally assess patients across emerging markets, ensuring they receive the critical treatment they need. ​ MedScore empowers pharmaceutical companies to effectively reach their underserved patients in Vietnam and the Philippines. By utilizing AI-powered scoring technology, MedScore can efficiently evaluate thousands of patients, streamlining the process and granting them access to breakthrough immunology treatment. ​ “ Our mission is to bridge the gap between patients in need and life-saving medications ,” said Olivia, CEO of MedScore. “With traditional low-digital methods often proving cumbersome and time-consuming, our technology offers a faster, more scalable solution specifically designed for the unique challenges of emerging markets.” ​ MedScore's comprehensive solution offers several key benefits: Enhanced Efficiency : AI-powered assessments streamline the patient evaluation process, enabling pharmaceutical companies to reach a wider pool of qualified patients. Improved Accuracy : Geo-location intelligence and banking-level underwriting ensure accurate patient selection for access programs. Scalability : MedScore's technology can be seamlessly deployed across multiple countries and regions, maximizing program reach. Faster Access to Treatment : By expediting the patient evaluation process, MedScore helps ensure patients receive timely access to critical treatment.